Your 30-Second Primer on this Week’s Hottest IPO, Spark Therapeutics
Insights - Spark Therapeutics (ONCE) lists publicly today, joining companies like bluebird bio (BLUE) and Avalanche (AAVL) as yet another emerging gene therapy player.
Read nowSearch Results for gene therapy
bluebird bio’s Treatment for a Rare Blood Disorder is Working
Insights - bluebird bio (BLUE) reported that two patients taking LentiGlobin had rapid and sustained responses to the gene therapy
Read now
Transcript of KOL Call: Urologist Talks Bladder Cancer and Lasting Side Effects
Insights - Participants PropThink Dr. Michael Chancellor, KOL Jonathan Kaufman, Lipella CEO PropThink Good afternoon everyone, welcome to PropThink’s Digital Conference. My name is Deniel Mero, Editor … Continue Reading
Read now
Transcript of Sarepta (SRPT) ELEVIDYS FDA Accelerated Approval Call
Transcripts - Operator Good afternoon, and welcome to the Sarepta Therapeutics ELEVIDYS FDA accelerated approval call. [Operator Instructions] As a reminder, today’s program is being recorded. At … Continue Reading
Read now
Call Transcript of OCUL 12-mos data from OTX-TKI for Wet AMD
Transcripts - Participants Antony Mattessich, Chief Executive Officer Arshad Khanani, KOL Peter Kaiser Chief Advisor for Retina Rabia Ozden, Chief Medical Officer Donald Notman, Chief Financial Officer Chris White, … Continue Reading
Read now
FDMT Phase 1/2 Cystic Fibrosis Interim Call Transcript
Transcripts - Participants August Moretti, Chief Financial Officer David Kirn, Chief Executive Officer Jennifer Taylor-Cousar, Lead Investigator of 4D-710 Ladies and gentlemen, thank you for standing by, … Continue Reading
Read now
Expectations for MGTA-145 in Mobilizing Myeloma Patients for Transplant
Insights - Magenta presented data for their mobilizing agent MGTA-145 at the European Society for Blood and Marrow Transplantation (EBMT 2021). The data was not new, but it gave … Continue Reading
Premium